Verifying…
Home / Drug A–Z / Vitricine Eye Drop

Vitricine Eye Drop

NAFDAC Reg. No. 04-4112 · Drug

Registered with NAFDAC — registration activeAs of 5 November 2026 · synced automatically from official sources.
Product
Vitricine Eye Drop
NAFDAC number
04-4112
Active ingredient
Tetrahydrozoline hydrochloride
Strength
0.05%
Form
Eye drops
Pack size
1 x 15 mL (in plastic bottle)
Manufacturer
Not listed
Applicant (holder)
Drugfield Pharmaceuticals Limited
Approved
21 Dec 2023
Status
Active View on NAFDAC ↗
Registration valid to
20 Dec 2028
WHO alerts
None found
Community reports
None
Times checked
0

RxVerify commentary

  • Vitricine Eye Drop is on the NAFDAC register with an active registration (04-4112). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.

What Vitricine Eye Drop is used for

From the official U.S. FDA label for tetrahydrozoline hydrochloride, the active ingredient registered with NAFDAC.

What it is used for

relieves redness of the eye due to minor eye irritations as a lubricant to prevent further irritation or to relieve dryness of the eye

Purpose

s Lubricant Redness reliever

Possible side effects

you experience eye pain changes in vision continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours

Warnings

For external use only Ask a doctor before use if you have narrow angle glaucoma When using this product pupils may become enlarged temporarily to avoid contamination, do not touch tip of container to any surface. Replace cap after using. if solution changes color or becomes cloudy, do not use overuse may produce increased redness of the eye remove contact lenses before using Stop use and ask a doctor if you experience eye pain changes in vision continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. …

Pregnancy & breastfeeding

If pregnant or breast-feeding, ask a health professional before use.

General information only — not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of Vitricine Eye Drop

Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.

3 free checks left today · no signup Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Vitricine Eye Drop

What is in Vitricine Eye Drop?

Vitricine Eye Drop contains Tetrahydrozoline hydrochloride (0.05%), as eye drops, according to its NAFDAC registration record.

Is Vitricine Eye Drop registered with NAFDAC?

Yes. Vitricine Eye Drop is listed on the NAFDAC register under registration number 04-4112, and its registration is active as of 5 November 2026.

Has Vitricine Eye Drop been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Vitricine Eye Drop in our automatically synced alert list.

How can I check that my pack of Vitricine Eye Drop is genuine?

Run a free authenticity scan with the NAFDAC number 04-4112, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Vitricine Eye Drop used for?

relieves redness of the eye due to minor eye irritations as a lubricant to prevent further irritation or to relieve dryness of the eye (Summarised from the official U.S. FDA label for tetrahydrozoline hydrochloride. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Vitricine Eye Drop? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.